NASDAQ · PAYS
Technology · Software - Infrastructure
$13.34
Up+$0.31 (+2.38%)
Updated Sep 11, 2026, 6:27 AM
SID Score
5.1/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
PAYS closed at $13.34 after 20 trading sessions, up 2.46% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $12.925 | $13.4399 | $12.74 | $13.34 | 821.16K |
| Sep 9, 2026 | $12.75 | $13.21 | $12.64 | $13.03 | 767K |
| Sep 8, 2026 | $13.51 | $13.51 | $12.71 | $12.88 | 1.1M |
| Sep 4, 2026 | $12.86 | $13.48 | $12.5527 | $13.45 | 938.29K |
| Sep 3, 2026 | $12.68 | $13.085 | $12.61 | $12.96 | 599.88K |
| Sep 2, 2026 | $12.36 | $12.66 | $12.22 | $12.53 | 505.94K |
| Sep 1, 2026 | $12.39 | $12.50 | $12.08 | $12.395 | 633.18K |
| Aug 31, 2026 | $12.92 | $12.94 | $12.11 | $12.46 | 1.09M |
| Aug 28, 2026 | $13.10 | $13.19 | $12.65 | $12.89 | 727.81K |
| Aug 27, 2026 | $13.26 | $13.6599 | $12.56 | $13.16 | 601.04K |
| Aug 26, 2026 | $13.91 | $14.02 | $13.11 | $13.23 | 779.71K |
| Aug 25, 2026 | $13.78 | $14.43 | $13.34 | $14.14 | 889.27K |
| Aug 24, 2026 | $14.145 | $14.41 | $13.5401 | $13.65 | 757.83K |
| Aug 21, 2026 | $13.91 | $14.25 | $13.71 | $14.09 | 984.02K |
| Aug 20, 2026 | $13.76 | $13.88 | $13.5143 | $13.82 | 496.74K |
| Aug 19, 2026 | $13.50 | $13.958 | $13.25 | $13.80 | 551.34K |
| Aug 18, 2026 | $13.00 | $13.74 | $12.72 | $13.52 | 739.33K |
| Aug 17, 2026 | $13.04 | $13.1612 | $12.72 | $13.00 | 612.35K |
| Aug 14, 2026 | $13.12 | $13.25 | $12.92 | $13.17 | 455.57K |
| Aug 13, 2026 | $12.85 | $13.15 | $12.5901 | $13.02 | 650.74K |
The latest Smart Investors Daily articles mentioning PAYS.
PAYS research
Company profile and research snapshot.
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 6, 2026 | DA Davidson | Buy | — |
| May 13, 2026 | DA Davidson | Buy | — |
| Mar 26, 2026 | DA Davidson | Buy | — |
| Mar 25, 2026 | Lake Street | Buy | — |
| Nov 13, 2025 | DA Davidson | Buy | — |
No generated briefing is available yet.
ChartMill · Sep 5, 2026
PAYSIGN (PAYS) triggers nearly all of Navellier's eight growth rules, with strong earnings revisions, surging sales, and high profitability making it a standout growth stock.
SeekingAlpha · Sep 2, 2026
Discover three Quant Strong Buy stocks with strong forward EPS growth that offer investors opportunities beyond the AI capex boom. Click here to see the top 3 stocks.
ChartMill · Sep 1, 2026
Paysign (PAYS) fits CAN SLIM with 450% EPS growth, 48% sales growth, strong momentum, and zero debt, but high valuation and volatility warrant caution.
Yahoo · Aug 28, 2026
Paysign (NASDAQ:PAYS) operates in two healthcare-focused businesses: payment services for plasma donors and pharmaceutical patient-affordability programs, Chief Financial Officer Jeff Baker said during a company presentation. Baker described the company as both a payments and life sciences business
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning PAYS.
